Cytokines in the brain during viral infection: Clues to HIV-associated dementia

Journal of Clinical Investigation

Volumn 100, Issue 12, 1997, Pages 2948-2951

  Griffin, Diane E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; NEOPTERIN; PROSTAGLANDIN E2;

BLOOD BRAIN BARRIER; BRAIN INFECTION; DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0031451973     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119847     Document Type: Review

References (32)

1. Irani, D.N., and D.E. Griffin. 1996. Regulation of lymphocyte homing into the brain during viral encephalitis at various states of infection. J. Immunol. 156:3850-3857.
2. Irani, D.N., K.-I. Lin, and D.E. Griffin. 1997. Regulation of brain-derived T cells during acute central nervous system inflammation. J. Immunol. 158: 2318-2326.
3. Aloisi, F., G. Penna, J. Cerase, B.M. Iglesias, and L. Adorini. 1997. IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159:1604-1612.
4. Cserr, H.F., and P.M. Knopf. 1992. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain a new view. Immunol. Today. 13: 507-512.
5. Akassoglou, K., L. Probert, G. Kontogoergos, and G. Kollias. 1997. Asirocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158:438-445.
6. Heyser, C.J., E. Masliah, A. Samimi, I.L. Campbell, and L.H. Gold. 1997. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. Natl. Acad. Sci. USA. 94:1500-1505.
7. Asensio, V.C., and I.L. Campbell. 1997. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J. Virol. 71:7832-7840.
8. Zinkernagel, R.M. 1996. Immunology taught by viruses. Science. 271: 173-178.
9. Biddison, W.E., R. Kubota, T. Kawanishi, D.D. Taub, W.W. Cruickshank, D.M. Center, E.W. Connor, U. Utz, and S. Jacobson. 1997. Human T cell leukemia virus type 1 (HTLV-1)-specific CD8+ CTL clones from patients with HTLV-1-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J. Immunol. 159:2018-2025.
10. Wesselingh, S.L., B. Levine, R.J. Fox, S. Choi, and D.E. Griffin. 1994. Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J. Immunol. 152: 1289-1297.
11. Moench, T.R., and D.E. Griffin. 1984. Immunocytochemical identification and quantitation of mononuclear cells in cerebrospinal fluid, meninges, and brain during acute viral encephalitis. J. Exp. Med. 159:77-88.
12. Levine, B., J.M. Hardwick, B.D. Trapp, T.O. Crawford, R.C. Bollinger, and D.E. Griffin. 1991. Antibody-mediated clearance of alphavirus infection from neurons. Science. 254:856-860.
13. Tyor, W.R., S.L. Wesselingh, J.W. Griffin, J.C. McArthur, and D.E. Griffin. 1995. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J. Acquired Immmune Defic. Syndr. Hum. Retrovirol. 9:379-388.
14. Tyor, W.R., J.D. Glass, J.W. Griffin, P.S. Becker, J.C. McArthur, L. Bezman, and D.E. Griffin. 1992. Cytokine expression in the brain during AIDS. Ann. Neurol. 31:349-360.
15. Sippy, B.D., P.M. Hofman, D. Wallach, and D.R. Hinton. 1991. Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. AIDS Res. Hum. Retroviruses. 10:511-521.
16. Wesselingh, S.L., C. Power, J. Glass, W.R. Tyor, J.C. McArthur, J.M. Farber, J.W. Griffin, and D.E. Griffin. 1993. Intracerebral cytokine mRNA expression in AIDS dementia. Ann. Neurol. 33:576-582.
17. Achim, C.L., M.P. Heyes, and C.A. Wiley. 1993. Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J. Clin. Invest. 91:2769-2775.
18. Wesselingh, S.L., K. Takahashi, J.D. Glass, J.C. McArthur, J.W. Griffin, and D.E. Griffin. 1997. Cellular localization of TNF-α mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/PCR in situ hybridization and immunohistochemistry. J. Neuroimmunol. 74:1-8.
19. Selmaj, K.W., and C.S. Raine. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339-346.
20. Barna, B.P., M.L. Estes, B.S. Jacobs, S. Hudson, and R.M. Ransohoff. 1990. Human astrocytes proliferate in response to tumor necrosis factor alpha. J. Neuroimmunol. 30:239-243.
21. Cheng, B., S. Christakos, and M.P. Mattson. 1994. Tumor necrosis factor protects neurons against metabolic-excitotoxic insults and promotes maintenance of calcium homeostasis. Neuron. 12:139-153.
22. Bogdan, I., S.L. Leib, M. Bergeron, L. Chow, and M.G. Tauber. 1997. Tumor necrosis factor-α contributes to apoptosis in hippocampal neurons during experimental group B streptococcal meningitis. J. Infect. Dis. 176:693-697.
23. Fine, S.M., R.A. Angel, S.W. Perry, L.G. Epstein, J.D. Rothstein, S. Dewhurst, and H.A. Gelbard. 1997. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes: implications for pathogenesis of HIV-1 dementia. J. Biol. Chem. 271:15303-15306.
24. te Velde, A.A., R.J. Huijbens, K. Heije, J.E. deVries, and C.G. Figdor. 1990. Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood. 76:1392-1397.
25. Awatsuji, H., Y. Furukawa, M. Hirota, Y. Murakami, S. Nii, S. Furukawa, and K. Hayashi. 1993. Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes. J. Neurosci. Res. 34:539-545.
26. Chao, C.C., T.W. Molitor, and S. Hu. 1993. Neuroprotective role of IL-4 against activated microglia. J. Immunol. 151:1473-1481.
27. Heyes, M.P., B.J. Brew, A. Martin, R.W. Price, A.M. Salazar, J.J. Sidtis, J.A. Yergey, M.M. Mouradian, A.E. Sadler, J. Keilp, et al. 1991. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:202-209.
28. Griffin, D.E., S.L. Wesselingh, and J.C. McArthur. 1994. Elevated central nervous system prostaglandins in HIV-associated dementia. Ann. Neurol. 35:592-597.
29. McArthur, J.C., T.E. Nance-Sproson, D.E. Griffin, O.A. Seines, E.N. Miller, J.B. Margolick, B.A. Cohen, H. Farzadegan, and A. Saah. 1992. The diagnostic utility of elevation in cerebrospinal fluid β2-microglobulin in HIV-1 dementia. Neurology. 42:1707-1712.
30. Brew, B.J., R.B. Bhalla, M. Paul, H. Gallardo, J.C. McArthur, M.K. Schwartz, and R.W. Price. 1990. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann. Neurol. 28:556-560.
31. Gelbard, H.A., H.S.L.M. Nottet, S. Swindells, M. Jett, K.A. Dzenko, P. Genis, R. White, L. Wang, Y.-B. Choi, D. Zhang, et al. 1994. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68:4628-4635.
32. Schwarcz, R., W.O. Whetsell, Jr., and R.M. Mangano. 1983. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science. 219:316-318.